Long-term function and psychosocial outcomes with venlafaxine extended release 75-225 mg/day versus placebo in the PREVENT study.

Watanabe, Koichiro; Thase, Michael E.; Kikuchi, Toshiaki; More

International Clinical Psychopharmacology ., Post Author Corrections: June 8, 2017

Effects of vilazodone on suicidal ideation and behavior in adults with major depressive disorder or generalized anxiety disorder: post-hoc analysis of randomized, double-blind,...

Thase, Michael E.; Edwards, John; Durgam, Suresh; More

International Clinical Psychopharmacology ., Post Author Corrections: May 19, 2017

Quetiapine XR monotherapy in major depressive disorder: a pooled analysis to assess the influence of baseline severity on efficacy

Thase, Michael E.; Montgomery, Stuart; Papakostas, George I.; More

International Clinical Psychopharmacology . 28(3):113-120, May 2013.

Efficacy of adjunctive aripiprazole in patients with major depressive disorder who showed minimal response to initial antidepressant therapy

Nelson, James Craig; Thase, Michael E.; Bellocchio, Elizabeth E.; More

International Clinical Psychopharmacology . 27(3):125-133, May 2012.

A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive ...

Martinez, James Michael; Katon, Wayne; Greist, John H.; More

International Clinical Psychopharmacology . 27(1):17-26, January 2012.

Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major...

Thase, Michael E.; Nierenberg, Andrew A.; Vrijland, Peter; More

International Clinical Psychopharmacology . 25(4):189-198, July 2010.

Which antidepressants have demonstrated superior efficacy? A review of the evidence

Montgomery, Stuart A.; Baldwin, David S.; Blier, Pierre; More

International Clinical Psychopharmacology . 22(6):323-329, November 2007.